Xiangyu Medical Co.,Ltd (688626.SS) SHH

Currency In CNY

AD

Valuation

Market Cap9.34B
Enterprise Value9.18B
P/E Ratio85.48
PEG Ratio20.51
Price/Sales Ratio8.61
Price/Book Ratio3.07
Enterprise/Revenue8.21
Enterprise/EBITDA66.63

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.1
Operating Margin0.06
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.04

Income Statement

Revenue767.75M
Revenue/Share4.93
Gross Profit511.54M
EBITDA138.27M
Net Income78.16M
Diluted EPS0.51

Balance Sheet

Total Cash646.34M
Total Cash/Share4.14
Total Debt340.87M
Total Debt/Equity0.16
Current Ratio2.1
Book Value Per Share13.89

Price History

52-Week Change-17.77
52-Week High95
52-Week Low35.37
Moving Average 50 Days40.52
Moving Average 200 Days50.98

Statistics

Average Volume2.46M
Shares Outstanding156.07M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.18
Trailing Annual Dividend Yield0.42
Payout Ratio0.05
Last Split FactorN/A
Last Split DateN/A
AD